Ziqing Qian
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
48
Citations
2,655
Est. group size
—
Recurring co-author estimate
Active years
18
Publishing since 2009
Ziqing Qian's research focuses on how molecules, especially peptides and oligonucleotides, can be delivered across cell membranes to reach targets inside cells. Much of the recent work applies this to designing oligonucleotide-based therapies for muscular dystrophies (like Duchenne muscular dystrophy and myotonic dystrophy) using an 'endosomal escape vehicle' delivery platform, while earlier work centered on the chemistry of cell-penetrating and cyclic peptides.
Publication output was higher and more variable earlier in the decade (peaking around 2018) and has slowed to roughly 1-3 papers per year in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Enhanced antisense oligonucleotide delivery reveals that transcript turnover impacts apparent splicing rescue in myotonic dystrophy
Molecular Therapy · 2026
- 654PPreclinical efficacy of ENTR-601-50, a novel EEV™-oligonucleotide construct for the treatment of exon 50 skip-amenable Duchenne muscular dystrophy
Neuromuscular Disorders · 2025
- Cell-Penetrating Peptides Translocate across the Plasma Membrane by Inducing Vesicle Budding and Collapse
Journal of the American Chemical Society · 2024
- 433P Therapeutic potential of ENTR-601-44, an Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugate for the treatment of exon 44 skip amenable DMD
Neuromuscular Disorders · 2024
- 431P Exon 45 skipping and dystrophin production with ENTR-601-45 in preclinical models of Duchenne muscular dystrophy
Neuromuscular Disorders · 2024
- The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disorders
Molecular Therapy — Nucleic Acids · 2023
- Targeting the Expanded <i>TCF4</i>/Fuchs’ Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates
ACS Omega · 2023
- DMD – ANIMAL MODELS
Neuromuscular Disorders · 2021
- Cell-Penetrating Peptides Escape the Endosome by Inducing Vesicle Budding and Collapse
ACS Chemical Biology · 2020
- Thymidine Phosphorylase Intracellular Enzyme Replacement Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) (3975)
Neurology · 2020
- Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide
Journal of Medicinal Chemistry · 2019
- Cyclic Cell‐Penetrating Peptides with Single Hydrophobic Groups
ChemBioChem · 2019
- Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library
Journal of the American Chemical Society · 2018
- Non‐Peptidic Cell‐Penetrating Motifs for Mitochondrion‐Specific Cargo Delivery
Angewandte Chemie International Edition · 2018
- Non‐Peptidic Cell‐Penetrating Motifs for Mitochondrion‐Specific Cargo Delivery
Angewandte Chemie · 2018
- Neuromuscular Disorders×5
- Journal of Medicinal Chemistry×2
- Journal of the American Chemical Society×2
- Angewandte Chemie International Edition×2
- Angewandte Chemie×2
- Ashweta Sahni
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Congcong Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Dan Shu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Fengmei Pi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Huan Zhang
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile